Moderna
MRNA
#947
Rank
โ‚ฌ19.44 B
Marketcap
50,59ย โ‚ฌ
Share price
-4.59%
Change (1 day)
-38.04%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: โ‚ฌ19.44 Billion

As of October 2024 Moderna has a market cap of โ‚ฌ19.44 Billion. This makes Moderna the world's 947th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2024

End of year Market Cap

Year Marketcap Change
2024โ‚ฌ19.44 B-43.3%
2023โ‚ฌ34.30 B-46.68%
2022โ‚ฌ64.33 B-29.25%
2021โ‚ฌ90.92 B170.54%
2020โ‚ฌ33.60 B471.97%
2019โ‚ฌ5.87 B33.89%
2018โ‚ฌ4.38 B

End of Day market cap according to different sources

On Oct 17th, 2024 the market cap of Moderna was reported to be:

โ‚ฌ19.44 Billion
by Yahoo Finance info icon info icon
โ‚ฌ19.44 Billion
by CompaniesMarketCap info icon info icon
โ‚ฌ19.44 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
โ‚ฌ91.83 M-99.53%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ256.74 B 1,220.18%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.76 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ35.15 B 80.79%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ218.22 B 1,022.08%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚ฌ2.39 B-87.71%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ365.39 B 1,778.83%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ2.74 B-85.87%๐Ÿ‡บ๐Ÿ‡ธ USA